tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Robert Willoughby, 55 are a BUY (67.07%), 24 are a HOLD (29.27%), 3 are a SELL (3.66%).
Analyst Robert Willoughby, carries an average stock price target met ratio of 50.89% that have a potential upside of 20.01% achieved within 238 days. Previously, Robert Willoughby worked at CREDIT SUISSE, BAML.
Robert Willoughby’s has documented 156 price targets and ratings displayed on 11 stocks. The coverage was on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on CVS, CVS Health Corp at 08-Aug-2022.
Analyst best performing recommendations are on ALGN (ALIGN TECHNOLOGY).
The best stock recommendation documented was for ALGN (ALIGN TECHNOLOGY) at 10/22/2020. The price target of $460 was fulfilled within 1 day with a profit of $6.77 (1.49%) receiving and performance score of 14.94.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Feb-2025
$209
$46.45 (28.58%)
$200
Buy Since 04-Feb-2021
$220
$41.57 (23.30%)
$200
Hold Since 21-Oct-2025
$188
$9.57 (5.36%)
$169
Buy Since 01-May-2025
$235
$56.57 (31.70%)
$220
Hold Since 26-Feb-2026
$200
$21.57 (12.09%)
$200
What Year was the first public recommendation made by Robert Willoughby?
